For stable, symptomatic patients with suspected CAD who are deemed to be at “minimal risk” using a CT-based tool, deferral of diagnostic testing is just as safe as the usual approach and is even ...

Approximately 80 percent of patients who have the hepatitis C virus may have been missed through EMR-reliant risk-based testing, according to research from the CDC. The paper, published in Clinical ...

“While home-based self-sampling for cervical cancer screening is an evidence-based strategy proven to increase screening ...

The assay is designed to encourage informed patient-physician decision-making when choosing a treatment option in localised ...

Cancer risk assessed by genome sequencing may give misleadingly high estimates if family history is not taken into account, according to a new study from the University of Exeter. The researchers ...

A prospective trial of gastrointestinal cancer patients showed the feasibility of preemptive genetic testing for DPYD/UGT1A1 variants associated with increased chemotherapy toxicity. Genotype-guided ...